Scientific advice to the European Commission on the internal review submitted under Regulation (EC) No 1367/2006 on the application of the provisions of the Aarhus Convention against the Commission Implementing Decision 2015/687 to authorise genetically modified oilseed rape MON88302
Following a request of the European Commission, the European Food Safety Authority (EFSA) reviewed the scientific arguments raised by Testbiotech against the Commission Implementing Decision 2015/687 authorising the placing on the market of products containing, consisting of, or produced from oilseed rape MON88302. Testbiotech, together with eight other non-governmental organisations, argued that the risk assessment of oilseed rape MON88302 performed by the EFSA GMO Panel is inadequate and flawed. EFSA analysed each of the scientific arguments put forward in the technical background of Testbiotech’s complaint on oilseed rape MON88302, and concludes that none of these arguments reveal new information that would invalidate the previous risk assessment conclusions and risk management recommendations on oilseed rape MON88302 made by the GMO Panel. Therefore, EFSA considers that the previous GMO Panel risk assessment conclusions and risk management recommendations on oilseed rape MON88302 remain valid and applicable.